Cognition Therapeutics, Inc
Price
FilingsNewest: Form 10-Q, quarterly reportNov 5 →Insiders3 insiders bought $32,492 in 3 open-market buys. No sales.→HoldersBios 6.3%Davenport & 4.5%Vanguard 3.6%→Financing →PeersClosest companies: ALEC, MPLT, TYRA→
From the filings
Figures
- Net income
- −$16.0Mlast 12 months
- Operating cash flow
- −$17.7Mlast 12 months
- Cash and equivalents
- $30.8Mat the last balance sheet
- Shares outstanding
- 95.1M shareson issue
Filings, newest first
- Nov 510-QQuarterly report
- Nov 58-KResults of operations
- Oct 228-KOther events
- Aug 710-QQuarterly report
- Aug 68-KResults of operations
- Jun 248-KOther events
- Jun 188-KShareholder vote
- Jun 48-KRegulation FD disclosure
- Apr 204Insider trade
- Apr 204Insider trade
- Mar 2610-KAnnual report